May 15, 2020 / 10:10 AM / 12 days ago

BRIEF-Oncopeptides Presents Pre-clinical Melflufen Data At AACR Annual Meeting 2020

May 15 (Reuters) - Oncopeptides AB:

* ONCOPEPTIDES PRESENTS PRE-CLINICAL MELFLUFEN DATA AT THE AACR ANNUAL MEETING 2020 THAT FURTHER VALIDATES THE TECHNICAL PLATFORM, PDC

* MELFLUFEN SHOWS HIGH EFFICACY AND SELECTIVITY IN BREAST CANCER CELLS COMPARED TO THEIR NORMAL DERIVED ISOGENIC COUNTERPARTS Source text for Eikon: Further company coverage: (Gdansk Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below